NCNA Competitors & Alternatives
Compare NuCana PLC with similar stocks in the same industry
Biotechnology
NCNA
Main Stock$1.36
Tradestie Score
51
Market Cap
$9.27M
P/E Ratio
0.0
Analyst Upside
+7547.1%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANRO
Alto Neuroscience Inc.
|
$24.78
|
$110.20M | - | 58 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 55 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$30.43
|
$76.55M | - | 58 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.28
|
$71.69M | - | 52 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.34
|
$67.94M | - | 56 | Compare |
|
TLPH
Talphera, Inc. Common Stock
|
$1.07
|
$42.55M | - | 59 | Compare |
|
PHIO
Phio Pharmaceuticals Corp. Common Stock
|
$1.00
|
$13.86M | - | 46 | Compare |
|
MBIO
Mustang Bio, Inc.
|
$0.70
|
$11.37M | - | 53 | Compare |
|
GLMD
Galmed Pharmaceuticals Ltd.
|
$0.57
|
$8.49M | - | 45 | Compare |
|
ADIL
Adial Pharmaceuticals, Inc
|
$2.90
|
$8.08M | - | 51 | Compare |
More NCNA Analysis
Data updated: Jul 06, 2026 | Industry: Biotechnology (SIC 2834)
237 stocks in this industry